SENSUS HEALTHCARE ($SRTS) is expected to release its quarterly earnings data on Thursday, May 15th after market close, per Finnhub. Analysts are expecting revenue of $7,379,088 and earnings of $0.03 per share.
You can see Quiver Quantitative's $SRTS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
SENSUS HEALTHCARE Insider Trading Activity
SENSUS HEALTHCARE insiders have traded $SRTS stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SRTS stock by insiders over the last 6 months:
- MICHAEL SARDANO (PRESIDENT AND GENERAL COUNSEL) purchased 1,000 shares for an estimated $5,950
- JAVIER RAMPOLLA (CHIEF FINANCIAL OFFICER) purchased 501 shares for an estimated $2,980
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SENSUS HEALTHCARE Hedge Fund Activity
We have seen 41 institutional investors add shares of SENSUS HEALTHCARE stock to their portfolio, and 23 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DIMENSIONAL FUND ADVISORS LP added 163,169 shares (+43.1%) to their portfolio in Q1 2025, for an estimated $771,789
- CITADEL ADVISORS LLC added 120,909 shares (+158.5%) to their portfolio in Q4 2024, for an estimated $836,690
- PACIFIC RIDGE CAPITAL PARTNERS, LLC added 114,500 shares (+inf%) to their portfolio in Q1 2025, for an estimated $541,585
- GOLDMAN SACHS GROUP INC removed 100,171 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $473,808
- MEROS INVESTMENT MANAGEMENT, LP added 88,478 shares (+inf%) to their portfolio in Q1 2025, for an estimated $418,500
- TWO SIGMA ADVISERS, LP removed 74,800 shares (-87.4%) from their portfolio in Q4 2024, for an estimated $517,616
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 67,269 shares (+81.2%) to their portfolio in Q4 2024, for an estimated $465,501
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SENSUS HEALTHCARE Analyst Ratings
Wall Street analysts have issued reports on $SRTS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Lake Street issued a "Buy" rating on 01/31/2025
To track analyst ratings and price targets for SENSUS HEALTHCARE, check out Quiver Quantitative's $SRTS forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
